{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:07:04Z","timestamp":1748891224887,"version":"3.40.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","award":["SFRH\/BD\/144222\/2019","SFRH\/BD\/120537\/2016","UIDB\/50006\/2020","UIDB\/50006\/2020","UIDB\/50006\/2020"],"award-info":[{"award-number":["SFRH\/BD\/144222\/2019","SFRH\/BD\/120537\/2016","UIDB\/50006\/2020","UIDB\/50006\/2020","UIDB\/50006\/2020"]}]},{"DOI":"10.13039\/501100012268","name":"PROTEOMASS Scientific Society","doi-asserted-by":"crossref","award":["#PM001\/2019 and #PM003\/2016","#PM001\/2019 and #PM003\/2016","#PM001\/2019 and #PM003\/2016"],"award-info":[{"award-number":["#PM001\/2019 and #PM003\/2016","#PM001\/2019 and #PM003\/2016","#PM001\/2019 and #PM003\/2016"]}],"id":[{"id":"10.13039\/501100012268","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study investigates the proteomic landscapes of chromophobe renal cell carcinoma (chRCC) and renal oncocytomas (RO), two subtypes of renal cell carcinoma that together account for approximately 10% of all renal tumors. Despite their histological similarities and shared origins, chRCC is a malignant tumor necessitating aggressive intervention, while RO, a benign growth, is often subject to overtreatment due to difficulties in accurate differentiation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a label-free quantitative proteomic analysis on solid biopsies of chRCC (n\u2009=\u20095), RO (n\u2009=\u20095), and normal adjacent tissue (NAT, n\u2009=\u20095). The quantitative analysis was carried out by comparing protein abundances between tumor and NAT specimens. Our analysis identified a total of 1610 proteins across all samples, with 1379 (85.7%) of these proteins quantified in at least seven out of ten LC\u2012MS\/MS runs for one renal tissue type (chRCC, RO, or NAT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our findings revealed significant similarities in the dysregulation of key metabolic pathways, including carbohydrate, lipid, and amino acid metabolism, in both chRCC and RO. Compared to NAT, both chRCC and RO showed a marked downregulation in gluconeogenesis proteins, but a significant upregulation of proteins integral to the citrate cycle. Interestingly, we observed a distinct divergence in the oxidative phosphorylation pathway, with RO showing a significant increase in the number and degree of alterations in proteins, surpassing that observed in chRCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study underscores the value of integrating high-resolution mass spectrometry protein quantification to effectively characterize and differentiate the proteomic landscapes of solid tumor biopsies diagnosed as chRCC and RO. The insights gained from this research offer valuable information for enhancing our understanding of these conditions and may aid in the development of improved diagnostic and therapeutic strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12014-023-09443-8","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T12:03:06Z","timestamp":1701172986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Proteomic analysis of chromophobe renal cell carcinoma and benign renal oncocytoma biopsies reveals shared metabolic dysregulation"],"prefix":"10.1186","volume":"20","author":[{"given":"Luis B.","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Susana","family":"Jorge","sequence":"additional","affiliation":[]},{"given":"Hugo","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Lodeiro","sequence":"additional","affiliation":[]},{"given":"Rajiv","family":"Dhir","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Campos Pinheiro","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Medeiros","sequence":"additional","affiliation":[]},{"given":"Hugo M.","family":"Santos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6276-8507","authenticated-orcid":false,"given":"Jos\u00e9 L.","family":"Capelo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"9443_CR1","unstructured":"Cancer Today. https:\/\/gco.iarc.fr\/today\/online-analysis-table?v=2018&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=1&include_nmsc_other=1 (2020)."},{"key":"9443_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumors of the urinary system and male genital organs\u2014part a: renal, penile, and testicular tumors. Eur Urol. 2016;70:93\u2013105.","journal-title":"Eur Urol"},{"key":"9443_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/CBM-2011-0176","volume":"9","author":"P Cairns","year":"2011","unstructured":"Cairns P. Renal cell carcinoma. Cancer Biomark. 2011;9:461\u201373.","journal-title":"Cancer Biomark"},{"key":"9443_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","volume":"75","author":"B Ljungberg","year":"2019","unstructured":"Ljungberg B, et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75:799\u2013810.","journal-title":"Eur Urol"},{"key":"9443_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15586\/jkcvhl.2017.96","volume":"4","author":"SE Wobker","year":"2017","unstructured":"Wobker SE, Williamson SR. Modern pathologic diagnosis of renal oncocytoma. J Kidney Cancer VHL. 2017;4:1\u201312.","journal-title":"J Kidney Cancer VHL"},{"key":"9443_CR6","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1021\/acs.jproteome.9b00248","volume":"18","author":"S Jorge","year":"2019","unstructured":"Jorge S, et al. Development of a robust ultrasonic-based sample treatment to unravel the proteome of OCT-embedded solid tumor biopsies. J Proteome Res. 2019;18:2979\u201386.","journal-title":"J Proteome Res"},{"key":"9443_CR7","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1021\/pr5010357","volume":"14","author":"D Rakus","year":"2015","unstructured":"Rakus D, Gizak A, Deshmukh A, W\u00efniewski JR. Absolute quantitative profiling of the key metabolic pathways in slow and fast skeletal muscle. J Proteome Res. 2015;14:1400\u201311.","journal-title":"J Proteome Res"},{"key":"9443_CR8","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1021\/acs.jproteome.5b00523","volume":"14","author":"JR Wi\u015bniewski","year":"2015","unstructured":"Wi\u015bniewski JR, et al. Absolute proteome analysis of colorectal mucosa, adenoma, and cancer reveals drastic changes in fatty acid metabolism and plasma membrane transporters. J Proteome Res. 2015;14:4005\u201318.","journal-title":"J Proteome Res"},{"key":"9443_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.molmet.2018.01.002","volume":"9","author":"E Walheim","year":"2018","unstructured":"Walheim E, Wi\u015bniewski JR, Jastroch M. Respiromics \u2013 An integrative analysis linking mitochondrial bioenergetics to molecular signatures. Mol Metab. 2018;9:4\u201314.","journal-title":"Mol Metab"},{"key":"9443_CR10","doi-asserted-by":"crossref","unstructured":"Wi\u015bniewski JR. Label-Free and standard-free absolute quantitative proteomics using the \u201ctotal protein\u201d and \u201cproteomic ruler\u201d approaches. In Methods in enzymology 2017 Jan 1 (Vol. 585, pp. 49-60). Academic Press","DOI":"10.1016\/bs.mie.2016.10.002"},{"key":"9443_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-021-02071-9","volume":"19","author":"S Jorge","year":"2021","unstructured":"Jorge S, et al. Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms. BMC Med. 2021;19:1\u201313.","journal-title":"BMC Med"},{"key":"9443_CR12","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1158\/0008-5472.CAN-20-0754","volume":"80","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, et al. Decreased mitochondrial DNA content drives OXPHOS dysregulation in chromophobe renal cell carcinoma. Cancer Res. 2020;80:3830\u201340.","journal-title":"Cancer Res"},{"key":"9443_CR13","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-20-1998","volume":"80","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, et al. Endocytosis-mediated replenishment of amino acids favors cancer cell proliferation and survival in chromophobe renal cell carcinoma. Cancer Res. 2020;80:5491\u2013501.","journal-title":"Cancer Res"},{"key":"9443_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367\u201372.","journal-title":"Nat Biotechnol"},{"key":"9443_CR15","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc. 2016;11:2301\u201319.","journal-title":"Nat Protoc"},{"key":"9443_CR16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731\u201340.","journal-title":"Nat Methods"},{"key":"9443_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-4939-7493-1_7","volume":"1711","author":"S Tyanova","year":"2018","unstructured":"Tyanova S, Cox J. Perseus: a bioinformatics platform for integrative analysis of proteomics data in cancer research. Methods Mol Biol. 2018;1711:133\u201348.","journal-title":"Methods Mol Biol"},{"key":"9443_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","volume":"18","author":"NT Doncheva","year":"2019","unstructured":"Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18:623\u201332.","journal-title":"J Proteome Res"},{"key":"9443_CR19","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkr988","volume":"40","author":"M Kanehisa","year":"2012","unstructured":"Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40:D109\u201314.","journal-title":"Nucleic Acids Res"},{"key":"9443_CR20","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","volume":"46","author":"A Fabregat","year":"2018","unstructured":"Fabregat A, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2018;46:D649\u201355.","journal-title":"Nucleic Acids Res"},{"key":"9443_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"9443_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbcan.2019.05.006","volume":"1872","author":"G Grasmann","year":"2019","unstructured":"Grasmann G, Smolle E, Olschewski H, Leithner K. Gluconeogenesis in cancer cells\u2013repurposing of a starvation-induced metabolic pathway. Biochimica et Biophysica Acta Rev Cancer. 2019;1872:24\u201336.","journal-title":"Biochimica et Biophysica Acta Rev Cancer"},{"key":"9443_CR23","doi-asserted-by":"publisher","first-page":"105882","DOI":"10.18632\/oncotarget.22413","volume":"8","author":"G K\u00fcrschner","year":"2017","unstructured":"K\u00fcrschner G, et al. Renal oncocytoma characterized by the defective complex I of the respiratory chain boosts the synthesis of the ROS scavenger glutathione. Oncotarget. 2017;8:105882\u2013904.","journal-title":"Oncotarget"},{"key":"9443_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","volume":"122","author":"L Vettore","year":"2020","unstructured":"Vettore L, Westbrook RL, Tennant DA. New aspects of amino acid metabolism in cancer. Br J Cancer. 2020;122:150\u20136.","journal-title":"Br J Cancer"},{"key":"9443_CR25","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.celrep.2015.10.059","volume":"13","author":"S Joshi","year":"2015","unstructured":"Joshi S, et al. The genomic landscape of renal oncocytoma identifies a metabolic barrier to tumorigenesis. Cell Rep. 2015;13:1895\u2013908.","journal-title":"Cell Rep"},{"key":"9443_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.trecan.2018.05.003","volume":"4","author":"D Lindgren","year":"2018","unstructured":"Lindgren D, Sj\u00f6lund J, Axelson H. Tracing renal cell carcinomas back to the nephron. Trends Cancer. 2018;4:472\u201384.","journal-title":"Trends Cancer"},{"key":"9443_CR27","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442\u201350.","journal-title":"Nucleic Acids Res"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-023-09443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-023-09443-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-023-09443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T12:03:14Z","timestamp":1701172994000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-023-09443-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["9443"],"URL":"https:\/\/doi.org\/10.1186\/s12014-023-09443-8","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"type":"print","value":"1542-6416"},{"type":"electronic","value":"1559-0275"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"10 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human kidney tissue samples were collected by the University of Pittsburgh Biospecimen Core, and the study was approved by the Institutional Review Board at the University of Pittsburgh (IRB # 02\u2013077).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}